Table 7.

Most 10 frequently cited publications on leishmaniasis research from Arab world during 1998–2017

SCR	Authors	Title	year of publication	Source title	Cited by
1st	Reithinger et al. [10]	Cutaneous leishmaniasis	2007	Lancet Infectious Diseases	685
2nd	Zijlstra et al. [55]	Post-kala-azar dermal leishmaniasis	2003	Lancet Infectious Diseases	282
3rd	Alrajhi et al. [48]	Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major	2002	New England Journal of Medicine	234
4th	El Tai et al. [51]	Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing	2000	Transactions of the Royal Society of Tropical Medicine and Hygiene	199
5th	Bacaër and Guernaoui [50]	The epidemic threshold of vector-borne diseases with seasonality: The case of cutaneous leishmaniasis in Chichaoua, Morocco	2006	Journal of Mathematical Biology	181
6th	Khalil et al. [52]	Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan	2000	Lancet	173
7th	Arnoult et al. [49]	On the evolution of programmed cell death: Apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization	2002	Cell Death and Differentiation	165
8th	Postigo [54]	Leishmaniasis in the World Health Organization Eastern Mediterranean Region	2010	International Journal of Antimicrobial Agents	148
9th	Pitta et al. [53]	IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani	2009	Journal of Clinical Investigation	146
10th	Zijlstra et al. [56]	Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan	2001	Tropical Medicine and International Health	140

SCR Standard competition ranking